So far, FDA staff have smoothly transitioned to mass-telework, the Office of New Drugs and Office of Generic Drugs directors said in an interview. • Source: File photo
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
